CADTH Pharmaceutical Reviews Update — Issue 12

See Pharmaceutical Reviews Update – Issue 12 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include:

• A new process for the submission and review of cell and gene therapies
• Updated guidelines on fees for CADTH pharmaceutical reviews
• Pending updates to the category 1 requirements
• Pending changes to CADTH conflict of interest policies
• A reminder about CADTH’s redaction policy
• Information about a new advisory committee for CADTH’s drug portfolio